The effects of fumonisin Bi (FBi) on the immune system of Sprague-Dawley rats were investigated. Groups of male and female rats (10 rats/group) were gavaged daily for 14 days with doses of 0, 5,15, and 25 mg/kg body wt/day and the primary (IgM) response to sheep red blood cells expressed as plaque-forming cell numbers/ 10* spleen mononuclear leukocytes (PFC/10 6 splenocytes) and PFC/ spleen was determined. There was a significant dose-related linear trend toward decreased PFC/10* splenocytes (p = 0.003) and PFC/ spleen cells (p = 0.001) in the male rats. Body weights, expressed as a percentage of the control, were significantly reduced (p = 0.002) in the male rats administered 15 and 25 mg/kg doses. The PFC numbers in female rats were not affected significantly by treatment (p > 0.05). For the remaining immunotoxicity studies, groups of male rats (10 rats/group) were gavaged with FBi doses of 0, 1, 5, and 15 mg/kg body wt/day for 14 days. There was a weakly significant dose-related trend toward increased numbers of serum immunoglobulin class G (p = 0.04). Also a significant dose-related increase (p = 0.013) in Listeria monocytogenes numbers was observed in the spleen at 24 hr postinfection. Treatment did not have a significant effect on organ weights, hematology, mitogen-induced lymphocyte transformation, calcium mobilization, the numbers of leukocytes and T-lymphocyte subsets, the natural killer cell activity, and phagocytosis (p 3= 0.05). These observations suggested that FB, may have indirect consequences for human health and warrant further investigations, s 1997 safety of Trafcctojy.
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Fusarium mycotoxins, including the T-2 toxin, deoxynivalenol, zearalenone, moniliformin, and fusarin C, are natural contaminants of com. Recently, a new group of mycotoxins called fumonisins has been isolated from corn contaminated with the fungus Fusarium moniliforme (Bezuidenhout ' To whom correspondence should be addressed at PL2202 Dl, Food Directorate, Health Protection Branch, Health Canada, Tunney's Pasture, Ross Avenue, Ottawa, Ontario, Canada K1A OL2. Fax: (613) 941-6959. et al, 1988; Cawood et al, 1991; Gelderblom et al, 1988) . Of these, fumonisin Bi (FB,) is the major contaminant of corn cultures and of naturally contaminated feed and foodstuffs Sydenham et al, 1991) .
FB! causes leukoencephalomalacia in horses (Marasas et al, 1988b) and pulmonary edema in swine (Harrison et al, 1990) . Rats treated with 50 mg FB,/kg diet for 26 months displayed hepatocarcinogenic and hepatotoxic effects . FB, has also been associated with an increased risk of esophageal cancer in the inhabitants of rural areas in Transkei, southern Africa (Marasas et al, 1988a; Shephard and Van Schalkwyk, 1992; Sydenham et al, 1990; Rheeder et al, 1992) .
While the effects of FBi are predominantly on the liver and kidneys (Riley et al., 1994; Voss et al, 1993 Voss et al, , 1995 the potential effects of this toxin on the immune system and immunosurveillance mechanisms should not be excluded. Effects on the immune system of chicken and calves have been reported for Fusarium moniliforme culture isolates known to produce fumonisin B, (Marijanovic et al, 1991; Osweiler et al, 1993) . Low levels of FB, (0.5-10 /ig/ml) caused significant cytotoxicity in chicken peritoneal macrophages in vitro (Qureshi and Hagler, 1992) . Higher levels of FB, (20, 40, or 100 fig/m\) added to chicken peritoneal macrophages in vitro caused morphological alterations including cytoplasmic blebbing, nuclear disintegration, and decreased phagocytosis (Qureshi and Hagler, 1992) . These results suggested that nonspecific parameters of the immune system including effects on the phagocytic lineagy of cells may be compromised by FB,. Such effects may ultimately influence other aspects of the immune system including humoral immunity and the ability of the animal to combat infection. In Balb/c mice, humoral immune responses following an ip injection of FB| were mixed, with no clear trend toward either suppression or stimulation (Martinova and Merrill, 1995) .
The present study was undertaken to investigate the potential effects of low levels of FB, on several aspects of the immune system of Sprague-Dawley rats in a 14-day oral (gavage) study.
MATERIALS AND METHODS
Fumonisin. Fumonisin B, was produced at the Plant Research Centre, Agriculture and Agri-Food Canada, as described by Miller et al. (1994) . For the experiments, FB lt 98% pure, was dissolved in sterile 0.9% saline and was prepared fresh each week.
Animals. Specific-pathogen-free male and female Sprague-Dawley rats (60 ± 5 g; Charles River Canada Inc., Montreal, Quebec, Canada) were housed individually in plastic cages under conditions meeting the requirements of the Canadian Council for Animal Care. Purina rat chow (Woodstock, Ontario, Canada) and water were provided ad libitum. Feed samples analyzed for fumonisins were not found to contain FB, and FB 2 at detection limits of 50 ng/FB,/g and 100 ng FB^g (Scott et al, 1995) . Upon arrival, rats were acclimatized for 1 week. Male rats were used for all experiments except for die plaque-forming cells (PFC) experiments in which male and female rats were used. With the exception of the PFC experiments, rats were randomly assigned to four treatment groups (8-10 rats/group; 12 rats/group were used for the Listeria monocytogenes infectivity assay). These included a vehicle control and three treated groups administered 1, 5, or 15 mg FB,/kg body wt/day. The PFC experiments included male and female rats (10 rats/group/sex) randomly assigned to a vehicle control and three treated groups administered 5, 15, and 25 mg of FB,/kg body wt/day. In addition, the PFC experiment included a positive control group of rats administered by gavage 10 mg/kg body wt/day cyclosporine A dissolved in olive oil and a vehicle control (olive oil). In all experiments the test or vehicle material was administered orally (by gavage) daily for 14 consecutive days.
Food consumption/body weight. The total amount of food consumed (g) and the body weights (g) for each rat were recorded daily starting 3 days prior to the commencement of treatment and ending with the day of autopsy.
Organ weights. The wet weights (g) of the brain, kidneys Qeft and right), liver, spleen, and thymus were recorded terminally.
Urine volume. Urine output and water consumption were measured for each of the 3 days prior to autopsy.
Hematology.
Peripheral blood cells were enumerated using the Coulter Counter Model S-Plus IV (Coulter Electronics Inc., Hialeah, FL) with the white blood cell (WBC) aperture current set at 150 V and the red blood cell (RBC) aperture current set at 190 V. The following parameters were measured: RBC counts (XlO'Vliter); hemoglobin (Hb) concentration (g/ liter) hematocrit (Hct); mean corpuscular volume (MCV) and mean corpuscular haemoglobin (MCH) (pg); mean corpuscular hemoglobin concentration (MCHC) (g/liter) red cell distribution width (RDW) (%); and WBC concentration (XlO'/liter). Leukocyte differential counts included eosinophils, neutrophils, segmented neutrophils, neutrophil bands, basophils, lymphocytes, and monocytes. Leukocyte differentials were obtained by multiplying die calculated percent of cells counted in 200 cells by the total WBC.
Spleen cell enumeration.
Leukocyte and lymphocyte concentrations in spleen mononuclear cell preparations were determined using the Coulter Counter Model S-Plus IV. Cell types were analyzed using a standard tricolor, phycoerythrin (PE) fluorescein isothiocyanate (FTTC) and biotinstreptavidin immunophenotyping technique. Anti-rat (IgGi) mouse monoclonal antibodies (Serotec Ltd, Oxford, England) included mouse anti-rat (IgGi) FITC or PE-labeled isotypic controls; OX-19 (CD5:biotin-streptavidin); W3/25 (CD4:FITQ; OX-8 (CD8:PE), OX-33 (FITC). Spleen single cell suspensions were prepared and adjusted to 1 x 10 7 mononuclear cells/ ml. Aliquots of the spleen cell suspension were incubated at room temperature (RT) with the appropriately diluted monoclonal antibodies. Following incubation, the samples were processed using a Q-Prep work station (Coulter). The preparations were washed 2x with PBS and fixed with 2% parafolmaldehyde (BDH Inc., Toronto, Ontario). Analysis of samples was accomplished using the FACScan flow cytometer (Becton-Dickinson, Mountain View, CA), equipped with an air-cooled argon-ion laser operating at 15 mV and emitting light at 488 nm. Results were compiled as a percentage of the lymphocyte gate and as absolute count (x lO'/ml) using the leukocyte count Immunoglobulin (Ig) levels. Total serum IgG and IgM were determined using a sandwich enzyme-linked immunosorbent assay (ELISA) (Bondy and Pestka, 1991) . ELISA plates were coated with polyclonal goat anti-rat IgG or IgM antibodies (Pierce, Rockford, IL). After blocking all wells with 1% bovine serum albumin in phosphate-buffered saline, triplicate samples of test sera or standards (rat immunoglobulin reference serum, ICN Immunobiologicals, Costa Mesa, CA) were added to each plate and incubated 60 min. Captured immunoglobulins were labeled with polyclonal goat anti-rat IgG or IgM conjugated to horseradish peroxidase (Pierce, Rockford, IL). Enzyme activity was detected with the substrate ABTS (Sigma Chemical Co., St. Louis, MO). The plates were read at a wavelength of 410 nm on a microplate reader (Molecular Devices Corporation, Menlo Park, CA). Immunoglobulin levels in test sera were determined using a four-parameter logistic curve fit to the standard curve.
Plaque-forming cell assay. The plaque-forming cell assay was a modification of that described by Cunningham and Szenberg (1968) . Rats were immunized intravenously (V) with 2X10* sheep red blood cells (SRBC) 4 days prior to termination of the study. At the termination of die study spleens were removed aseptically and single-cell suspensions were prepared by pressing the spleens through a polyester woven filter (spectra/mesh, Spectrum, Houston, TX). For die assay, predetermined optimum quantities of SRBC, spleen cells and guinea pig complement (Gibco BRL, Burlington, Ontario) were added to a prewarmed agar/dextran mixture (0.5% BactoAgar and 0.05% DEAE dextran in balanced salt solution). The mixture was poured into a petri dish and covered widi a glass coverslip. The plates were incubated at 37°C for 3 hr and plaques were enumerated. The IgM PFC/ 10* splenocytes and PFC/spleen were calculated and statistically analyzed.
Lymphocytes transformation. Lymphocyte transformation (incorporation of [methyl-
3 H]thymidine ([ 3 H]TdR); ICN Radiochemicals, Quebec, Canada) was measured using a previously described method (Smialowicz et al., 1989) . Suspensions of 5 X 10 3 viable spleen cells were prepared in complete medium (CM)-RPM1 1640 (Gibco BRL) supplemented with 10% (v/v) fetal calf serum (Gibco), 1% penicillin/streptomycin (Gibco), and 2-mercaptoethanol (Gibco). Spleen cells were cultured with predetermined optimum dilutions of concanavalin A (Con A, 4 |ig/ml in CM, in Sigma Chemical Co.) pokeweed mitogen (PWM, 10% in CM, Gibco BRL) and Salmonella typhimurium (STM, 160 //g/ml, CM, Ribi ImmunoChem Research Inc., Hamilton, MO) in 200-/zl volumes. The microplates were incubated at 37°C, in a 5% CO 2 incubator for 72 hr, and pulsed widi 0.5 fid [ 3 H]TdR for an additional 18 hr. Cells were harvested onto filter paper disks using die Titertek Cell Harvester system (Flow Laboratories, Missisauga, Ontario), transferred to vials containing 10.0 ml Econofluor (NEN Research Prds, Boston, MA) and die radioactivity measured using a Beckman 4000 liquid scintillation system (Beckman Instruments, Fullerton, CA). Results were expressed as counts per minute (cpm). The mean cpm of the quadruplicate cultures was calculated and data were normalized by logarithmic transformation for statistical analysis.
Calcium mobilization. Calcium mobilization was measured using a previously described method widi some modifications (Sei and Arora, 1991) . Spleen mononuclear cells were adjusted to 5 x 10* cells/ml CM. The probe FLUO-3 was added to die cell suspension at a final concentration of 3 fiM. Cells were incubated 20 min at 37°C, diluted 1:5 with CM, incubated 40 min at 37°C, washed 3x with CM, and resuspended to 2.5 X 10 6 cells/ml CM. Aliquots of FLUO-3 loaded cells were analyzed for background levels using die FACScan flow cytometer (Becton-Dickinson, Mountain View, CA) equipped widi an air-cooled argon-ion laser operating at 15 mV and emitting the light at 488 nm. The flow rate was adjusted to 1000-1500 cell/sec. Con A (final concentration 10 /ig/ml CM) was added to the cell preparation and die histogram of die emission on FL1 versus time was recorded every 30 sec from 0 to 300 sec post-Con A stimulation. The maximum mean fluorescence intensity (maximum mean fluorescence intensity/mean fluorescence intensity at Time sec), and the time to maximum mean fluorescence intensity were calculated and statistically analyzed.
Natural killer cell activity. The natural killer cell activity was measured using a previously detailed 4-hr chromium ("Cr) release assay (Smialowicz et al., 1989) . Spleen single-cell suspensions were prepared in CM and adjusted to give effector (E) to tumor YAC-1 target (T) cell ratios (E:T) of 100:1, 50:1, and 25:1. Controls included a spontaneous "Cr-release control (target cells + medium) (SR) and a total "Cr release control (target cells + 10% Tween 20) (TR). Supematants were harvested using a Skatron supernatant collection system (Mandell Scientific, Rockwood, Ontario). Radioactivity in CPM was measured using a Beckman 4000 gamma counter (Beckman Instruments). Percentage of cytotoxicity was calculated as
Phagocytosis. The phagocytic activity of monocytes and granulocytes in peripheral blood was measured using opsonized, FITC-labeled Escherichia coli bacteria according to a commercially available Phagotest kit (Orpegen, New Concept Scientific, Burlington, Ontario). The mean fluorescence intensity (MFI) of bacteria in the phagocytic cells and the percentage of phagocytic cells in peripheral blood were determined using the Becton-Dickinson FACScan.
Listcria monocytogenes infectivity assay. At the termination of treatment, 12 male rats/dose group were injected iv with a sublethal dose (4.55 X 10 7 bacteria/ml) of L monocytogenes suspension in physiologic saline according to previously established procedures (Tryphonas et al., 1991) . Four rats/group were terminated at 24, 48, and 72 hr postinjection. The spleens were aseptically removed and single-cell suspensions were prepared. Serial twofold dilutions of the spleen/bacteria suspensions were prepared in peptone water and 0.1 -ml aliquots were plated on trypticase soya agar. Colony-forming bacteria were enumerated using an automated colony counter (Biotran n, Automated Colony Counter, NBS Model Cl 11, New Brunswick Scientific Co., Inc., Edison, NJ).
STATISTICAL METHODS
Average daily food consumption during the study was calculated for each rat. For each rat, the following linear growth curve was fit to the body weight data:
where a represents the body weight (g) on Day 0 and /? represents the rate of growth (g/day). The average daily food consumption and the parameter estimates from model (1) were analyzed using a one-way analysis of variance (ANOVA) model with treatment as the main effect. A test for linear trend in the response variables versus dose (Armitage, 1973) was carried out.
A preliminary analysis indicated that terminal body weight was not linearly related to the weight of the brain. Also terminal body weights did not show a significant treatment effect (p > 0.05). Therefore, ANOVA was used for the analysis of the brain weights and analysis of covariance (ANCOVA) with body weight as the covariate was used for the analysis of kidney, liver, spleen and thymus weights. Similarly, ANOVA was used to statistically evaluate the urine output and serum immunoglobulin data.
The PFC data were log transformed and analyzed using a two-way ANOVA model. A test for linear trend in the response variables versus dose (Armitage, 1973) was carried out. Pairwise t tests were used to compare the control to the treated groups. A preliminary analysis indicated that the terminal body weights for the PFC experiments were linearly related to the weight of the spleen. Therefore, ANCOVA with body weight as a covariate was used for the analysis of the spleen weights (Shirley, 1977) .
For the lymphocyte transformation data, a two-way ANOVA model with day and treatment as the main effects and the interaction term was fit separately for each mitogen. Nonsignificant interactions (p * 0.15) were then dropped from the model. If an interaction involving treatment was not left in the model and there was a significant treatment effect, pairwise / tests between the control and the 1-, 5-, and 15-/jg dose groups were carried out.
For the calcium mobilization data a statistical analysis was performed for each measure across time by fitting nonlinear models and by analyzing estimates of maximum fluorescence and time to maximum fluorescence.
Data for the NK cell activity, phagocytosis, and L. monocytogenes infectivity assay were analyzed using univariate or multivariate ANOVA models (Morrison, 1976) .
In all cases, data were tested for normality (Shapiro and Wilk, 1965 ) and screened for outliers (Bamett and Lewis, 1978) .
RESULTS
There were no treatment-related effects for either the mean daily food consumption (p = 0.16) or for the parameter estimates from the growth curve model (parameter a: initial body weight, p = 0.65; parameter /?: growth rate, p = 0.18; data not shown). Similarly, there were no treatment-related effects for any of the organ weights (p > 0.05).
The covariate analysis of water consumption was significant (p < 0.001) indicating that as water consumption increased, so did urine output. The average water consumption was slightly higher for the control (mean ± SE, 39.03 ± 1.33) compared to the treated groups (mean ± SE, 35.67 ± 1.49; 34.98 ± 1.50; and 36.27 ± 0.90 for the 1-, 5-, and 15-mg/kg groups, respectively) although water consumption did not show a significant treatment effect (p = 0.17) (data not shown). Similarly, the average urine output was highest for the controls (mean ± SE, 21.17 ± 0.86) compared to the treated groups (mean ± SE, 18.84 ± 0.89; 17.69 ± 0.86; and 19.78 ± 0.73) for the 1, 5, and 15 mg/kg groups, respectively (data not shown).
There were no significant differences between the control and the treated groups for any of the hematological parameters measured or for any of the peripheral blood cell types analyzed with flow cytometry (p > 0.05) (data not shown).
Rat No. 23 dosed with 5 mg/kg body wt/day had a high IgG level relative to the rest of the group. There were no abnormal hematological or microbiological findings to justify the observed increase in IgG levels in this rat. Therefore, the statistical analysis of the IgG data was performed with and without rat No. 23. A weakly significant linear trend (p = 0.04) was noted in the IgG levels only when rat No. 23 was excluded from the analysis (Table 1) .
For the male rats a significant dose-related linear trend toward decreased numbers of PFC/10 6 splenocytes (p = 0.003) and PFC/spleen (p = 0.001) was noted as the dose of fumonisin increased (Table 2) . Pairwise comparisons (paired t test) indicated a significant decrease in the percent- age PFC/10 6 cells and PFC/spleen of rats dosed with 25 mg FBi/kg body wt/day dose (p =s 0.05). There were no significant differences in spleen weights between the control and treated groups (p > 0.05). However, a significant decrease in percentage of body weights relative to the control was observed in rats dosed with 15 and 25 mg FBi/kg body wt/ day (p =£ 0.05) ( Table 2 ). For the female rats there were no significant treatment-related effects (p > 0.05) on the numbers of PFC/10 6 splenocytes (mean log 2 ± SE, range; Control: 6.51 ± 0.17, 5.69-7.35; 5 mg/kg: 6.34 ± 0.30, 4.47-7.41; 15 mg/kg: 6.52 ± 0.37, 4.54-7.54; 25 mg/kg: 6.45 ± 0.33, 4.71-7.78; data not shown) or on the numbers of PFC/ spleen (mean log 2 ± SE, range; Control: 5.60 ± 0.02, 4.90-6.86; 5 mg/kg: 5.29 ± 0.31, 3.40-6.31; 15 mg/kg: 5.51 ± 0.35, 3.81-6.72; 25 mg/kg: 5.56 ± 0.35, 3.81-6.91; data not shown).
A significant reduction in the number of PFC/10 6 splenocytes (p = 0.004) and PFC/spleen (p = 0.002) was observed in the cyclosporin A-treated group compared to the control (Table 2) . Similarly, significantly decreased spleen weights (p = 0.05) and adjusted spleen weights (p < 0.001) were observed in the cyclosporin A-treated group compared to the control (data not shown).
There were no significant treatment-related effects on the mitogen-induced lymphoproliferative activity of rat spleen mononuclear cells (p > 0.05) or on the intracellular Con Ainduced calcium levels (p > 0.05) (data not shown). Similarly, there were no significant treatment-related effects on the NK cell activity (p > 0.05) or on the phagocytic activity of peripheral blood mononuclear phagocytes (p > 0.05) (data not shown).
A significant dose-related trend toward increased numbers of bacterial colonies was observed at 24 hr postinfection with L monocy to genes (p s= 0.013) (Fig. 1) .
DISCUSSION
The present study indicated that the humoral immune response of Sprague-Dawley male rats was significantly affected by FBi treatment. In this study, the IgM response to SRBC, measured by enumerating PFC/10 6 splenocytes and the PFC/spleen, was affected in a dose-related fashion with the treated groups having uniformly lower anti-SRBC PFC numbers compared to the control. A pairwise comparison between each of the treated groups and the control indicated that the PFC numbers were significantly different from the control only at the 25 mg/kg body wt/day dose. At this dose level the terminal body weights of rats also decreased significantly compared to the control suggesting that toxicity may have, in part, influenced the PFC numbers indirectly.
Similar effects on humoral immunity have also been reported by Marijanovic et al. (1991) and by Martinova and Merrill (1995) . Marijanovic et al. (1991) fed culture isolates of moniliforme, which are known producers of FB,, to chicken for 6 weeks. A reduction in serum levels of antibodies to SRBC and Brucella abortus were reported for the treated chicken compared to the control (Marijanovic et al., 1991) . Martinova and Merrill (1995) reported on the effects of FB, on the PFC numbers in mice immunized with SRBC either concurrently with or prior to treatment initiation. In these experiments, however, the direction of the response to SRBC was related to the time the animals were immunized relative to treatment and the duration of treatment. Thus, a significant increase in the response to SRBC over the control was evident when SRBCs were administered prior to treatment with varying doses of FB, while a decrease in the response to SRBC was observed when a single dose of FB! was administered concurrently with SRBC immunization. Furthermore, the response to SRBC in the untreated (control) group was unusually low which raises the question of whether the SRBC dose used for immunization was optimized for maximum antibody production. For these reasons, interpretation of these data can only be speculative.
In the present study, the effect on the PFC numbers were observed in the male rats only suggesting that the effects of fumonisin may be gender related. Similar sex-associated differences between male and female rats have also been reported for other toxicological endpoints (Bondy et al., 1996) . While the reason for the differences in sensitivity to fumonisin treatment between male and female rats is not clear, it has been previously shown that after a single oral dose of FB! most of the toxin appears in the feces of rats within 24 hr with trace amounts of the administered toxin appearing in the urine, liver, kidneys, and red blood cells (Shepard et al., 1992a (Shepard et al., , 1992b . Although FB, is rapidly cleared from the blood, elevated levels of free sphingosine and sphinganine and elevated free sphinganine:sphingosine ratios have been detected in the kidney and liver of male compared to female rats (Riley et al., 1994) . Since FBi is a potent inhibitor of ceramide synthase, an enzyme critical to sphingolipid biosynthesis, and since sphingolipids play multiple roles in cellular function (Merill et al., 1996) , it is likely that the observed functional alterations of the immune system are related to disruption of these pathways.
While the data unequivocally indicate that FB, treatment resulted in immunosuppression in the male rats, the mechanism of action of FB, on the multistage events involved in T lymphocyte-dependent immune responses to antigens such as SRBC are not well understood. It is possible that fumonisin may have affected the function of the phagocytic cells since FB| treatment had a profound effect on the clearance of L monocytogens by FE^-treated rat spleens at 24 hr following injection with the bacteria at which time clearance by the phagocytic mononuclear lineage of cells is most crucial (Cheers et ai, 1978) . While there were no significant effects on the in vitro phagocytic activity of peripheral blood monocytes and granulocytes in the present study, others (Qureshi and Hagler, 1992) have noted morphological alterations including cytoplasmic blebbing and nuclear disintegration in chicken peritoneal macrophages incubated in vitro to 0.5, 5.0, and 10.0 Mg FB,/ml. It is possible, therefore, that the observed lag in the clearance of Listeria during the first 24 hr as observed in the present study was a consequence of a defect in the cell's ability to enter the respiratory burst activity phase.
In summary, results of this study indicated that FB, significantly affected the humoral immunity of male but not female rats. This was shown by a dose-related decrease in the SRBC PFC numbers of rats gavaged daily with doses of FB i ranging from 5 to 25 mg/kg body wt. The ability of male rat splenocytes to clear the L. monocytogenes from the circulation was also compromised at the early stages of infection suggesting that the mononuclear phagocytic cell function may be affected by treatment. However, at 72 hr all groups of rats were successful in eliminating the bacteria and thus overcoming the Listeria infection. This, combined with the observation that several other immune related parameters investigated in the same rats who were administered FB! doses up to 15 mg/kg body wt of FBi were not affected by treatment suggested that the observed effects may have not been of clinical significance. However, the potential consequences the observed immunosuppression would have on rat and indirectly on human health following long-term exposure to FB, is not known. Consequently, further research focused on the potential immunotoxic effects of FB, using long-term feeding strategies is required.
